Navigation Links
Regulus to Present at 32nd Annual J.P. Morgan Healthcare Conference
Date:1/7/2014

Ac-conjugated anti-miR targeting microRNA-122, for the treatment of chronic hepatitis C virus infection. Regulus' commitment to innovation and its leadership in the microRNA field have enabled the formation of strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi. In addition, Regulus has formed a research collaboration with Biogen Idec around its emerging microRNA biomarkers platform.

For more information, please visit http://www.regulusrx.com

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements associated with Regulus' expectations regarding future therapeutic and commercial potential of Regulus' business plans, technologies and intellectual property related to microRNA therapeutics being discovered and developed by Regulus. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "intends," "will," "goal," "potential" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Regulus' current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks associated with the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs. These and other risks concerning Regulus' programs are described
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Regulus to Present at 12th Annual Needham Healthcare Conference
2. Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical Development
3. Regulus to Present at the Lazard Capital Markets Healthcare Conference
4. Regulus Files Registration Statement for Proposed Initial Public Offering
5. Regulus Therapeutics Appoints Bruce Carter to its Board of Directors
6. Regulus Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate
7. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 16TH ANNUAL NEEDHAM GROWTH CONFERENCE
8. Scioderm to Present at 32nd Annual J.P. Morgan Healthcare Conference
9. GlySure CEO to Present CE Mark Trial Results at OneMedForum 2014
10. Arcturus Therapeutics, Inc. to Present at the Biotech Showcase 2014
11. PAREXEL International To Present At JP Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Md. (PRWEB) January 22, 2015 ... its new UV-1280 multipurpose UV-visible spectrophotometer. Offering wavelength ... high-quality instrument is ideal for applications in a ... life science. , The user-friendly UV-1280 enables intuitive ...
(Date:1/22/2015)... Bedford, NH (PRWEB) January 22, 2015 ... offers a table top laboratory homogenizer, the PandaPLUS 2000, ... nanoparticles, nanodispersions, nanoemulsions , and cell disruption . ... processing dairy products, fruit juices, liquid food, food additives ...
(Date:1/22/2015)... Mass (PRWEB) January 21, 2015 Cambridge Semantics, ... Web technology, today announced that 2014 was a record-breaking year ... the capabilities of the Anzo Smart Data Platform and our ... and utilize insights from diverse data which led to record ...
(Date:1/22/2015)... Johnston, RI (PRWEB) January 22, 2015 ... State , The growing team of brand-neutral, independent consultants, ... CIO Philip Rogers explained that over the years, his ... including , Moroso, Town of Plainfield, as well as ...
Breaking Biology Technology:Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Cambridge Semantics Announces Record Results for 2014 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2
... 21, 2010 The Pharmaceuticals practice,at MarketsandMarkets is pleased to announce a ... , , ... Calorie/Diet Beverages Market (2010,-2015)Market Report. Early buyers will receive 10% customization of reports, ... ...
... ... today announced an agreement under which Therapure will provide manufacturing ... Israel with an executive management team based in Woburn, MA. Under ... clinical manufacturing for one of ProChon’s products, which may be used ...
... Minnesota-led researchers has cleared a major hurdle in the drive ... as high as current levels, which rarely exceed 30 percent. ... from semiconductors in solar cells can be captured and transferred ... for solar cell researchers seeking to build cheaper, more efficient ...
Cached Biology Technology:World Low Calorie/Diet Beverages Market (2010 -2015): MarketsandMarkets 2World Low Calorie/Diet Beverages Market (2010 -2015): MarketsandMarkets 3Therapure Biopharma Inc. Signs Biomanufacturing Contract with ProChon Biotech Ltd. 2University of Minnesota researchers clear major hurdle in road to high-efficiency solar cells 2
(Date:1/22/2015)... WINSTON-SALEM, N.C. , Jan. 16, 2015  A man-made ... working memory and other mental capabilities in adults with ... a pilot study led by researchers at Wake Forest ... 60 adults diagnosed with amnesic mild cognitive impairment (MCI) ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... of the "Global Wearable Technologies Market and ... Overview, Trends and Forecast 2014-2020" report to ... are smart devices that can be worn on ...
(Date:12/22/2014)... Dec. 22, 2014 Research and Markets ... the "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight ... watermarking and fingerprinting markets. Watermarking aims to control ...
Breaking Biology News(10 mins):Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2The Global Watermarking and Fingerprinting Markets 2
... at UC Santa Barbara have discovered a caste of ... fluke species that invades the California horn snail. The ... the Proceedings of the Royal Society B . ... killer morphs defending the colony," said Armand M. Kuris, ...
... Menachem Shoham, PhD, associate professor and researcher in ... University School of Medicine, has identified new anti-pathogenic drugs ... Aureus (MRSA) harmless by preventing the production of toxins ... a growing public health problem causing 20,000 deaths per ...
... the support of an $11.8 million, five-year federal grant, ... are developing a quick-dissolving vaginal film containing a powerful ... they plan to begin testing it locally within a ... deliver breath fresheners, could have several advantages over vaginal ...
Cached Biology News:'Warrior worms' discovered in snails; UCSB scientists see possible biomedical applications 2Case Western Reserve researcher discovers new 'anti-pathogenic' drugs to treat MRSA 2Pitt gets $11.8 million to develop microbicide films for HIV prevention 2